Superior glycemic control was achieved with the combination of automated insulin titration guidance and support from healthcare professionals compared with support from healthcare professionals alone, a new study found. Researchers recruited patients from 3 diabetes centers in the US who were eligible if they were aged 21‒70 years, diagnosed with type 2 diabetes (T2D) with a glycated hemoglobin (HbA1c) concentration of ≥7.5%, and ≤11%, and had been using the same insulin regimen for the previous 3 months. Eligible participants were randomly assigned 1:1 to either the d-Nav Insulin Guidance System and healthcare professional support (intervention group) or healthcare professional support alone (control group). The primary outcome was to compare average change in HbA1c from baseline to 6 months. They found:
- 181 of 236 patients screened for eligibility were enrolled and randomly assigned to the intervention (n=93) and control (n=88) groups.
- At baseline, mean HbA1c was 8.7% in the intervention group and 8.5% in the control group.
- The mean decreased in HbA1c from baseline to 6 months was 1.0% in the intervention group and 0.3% in the control group.
Bergenstal RM, Johnson M, Passi R, et al. Automated insulin dosing guidance to optimize insulin management in patients with type 2 diabetes: A multicenter, randomized controlled trial. [Published online ahead of print February 22, 2019]. Lancet. doi:10.1016/S0140-6736(19)30368-X.
This Week's Must Reads
AHA Statement: Accurate Measurement of BP, Hypertension; ePub 2019 Mar 4; Muntner, et al
Coffee Consumption & Plasma Biomarkers, Am J Clin Nutr; ePub 2019 Mar 5; Hang, et al
Is Adding Aspirin to Warfarin Therapy Beneficial? , JAMA Intern Med; ePub 2019 Mar 4; Schaefer, et al
Urinary Oxalate Excretion & Risk of CKD Progression, JAMA Intern Med; ePub 2019 Mar 4; Waikar, et al
Psychosocial Stress & CV Health in Older Women, Circulation; ePub 2019 Feb 28; Burroughs-Peña, et al
Must Reads in Diabetes
Insulin Management in Patients with T2D, Lancet; ePub 2019 Feb 22; Bergenstal, et al
Hospitalization Rates in Young-Onset Diabetes, Ann Intern Med; ePub 2019 Jan 15; Ke, Lau, et al
Long-Term Absolute Risk for CVD by FG Level, Diabetes Care; ePub 2019 Jan 7; Bancks, et al
Prediabetes Status & Lifestyle Modification , J Am Board Fam Med; 2019 Jan 4; Owei, et al
Second-Line ADMs & CV Events in T2D, JAMA Netw Open; ePub 2018 Dec 21; O’Brien, et al